Koyfin Home > Directory > Health Care > Amicus Therapeutics > EV / EBITDA (ntm)

Amicus Therapeutics EV / EBITDA (ntm) Chart (FOLD)

Amicus Therapeutics annual/quarterly EV / EBITDA (ntm) from 2010 to 2010. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Amicus Therapeutics EV / EBITDA (ntm) for the quarter ending June 06, 2010 was 0.31
Other Valuation Metrics:
  • Amicus Therapeutics Market Cap for the quarter ending March 03, 2018 was $2,811m a 48.80% increase of 1,372m year over year
  • Amicus Therapeutics Price / Book for the quarter ending March 03, 2018 was 7.12 a 34.98% increase of 2.49 year over year
  • Amicus Therapeutics Enterprise Value for the quarter ending March 03, 2018 was $2,617m a 49.70% increase of 1,301m year over year
View Chart On Koyfin

Quarterly FOLD EV / EBITDA (ntm) Data

06/20100.31